Revenue Breakdown
Composition ()
No data
Revenue Streams
KORU Medical Systems Inc (KRMD) generates its revenue through a diversified portfolio of business segments. Currently, the largest contributor to its top-line growth is Domestic Core, accounting for 58.9% of total sales, equivalent to $6.12M. Other significant revenue streams include International Core and Novel Therapies. Understanding this composition is critical for investors evaluating how KRMD navigates market cycles within the Medical Equipment, Supplies & Distribution industry.
Profitability & Margins
Evaluating the bottom line, KORU Medical Systems Inc maintains a gross margin of 58.26%. This metric reflects the company's pricing power and manufacturing efficiency. Further down the income statement, the operating margin stands at -8.34%, while the net margin is -7.48%. These profitability ratios, combined with a Return on Equity (ROE) of -21.71%, provide a clear picture of how effectively KRMD converts its operational activities into shareholder value.
Comparative Benchmarking
In the context of the broader market, KRMD competes directly with industry leaders such as AVR and STXS. With a market capitalization of $257.55M, it holds a significant position in the sector. When comparing efficiency, KRMD's gross margin of 58.26% stands against AVR's 71.33% and STXS's 54.94%. Such benchmarking helps identify whether KORU Medical Systems Inc is trading at a premium or discount relative to its financial performance.
